Targeting BCL11B in chimeric antigen receptor-engineered lymphoid progenitors propagates adaptive NK-like cell responses against leukemia
Preview
Cite
Access Statistic

Rights
Use and reproduction:
All rights reserved
Use and reproduction:
All rights reserved